Literature DB >> 18303252

Telemedically provided stroke expertise beyond normal working hours. The Telemedical Project for Integrative Stroke Care.

Bijan Vatankhah1, Johannes Schenkel, Andrea Fürst, Roman L Haberl, Heinrich J Audebert.   

Abstract

BACKGROUND: State-of-the-art stroke management requires neurological expertise for the recognition of complex cerebrovascular syndromes or stroke-mimicking symptoms and initiation of proven acute therapies. Many community hospitals struggle to fulfill these premises particularly at evening/nighttimes or weekends. Telemedicine can improve that situation by offering rapid access to neurological expertise, but it has not been shown to what extent it is used beyond working times.
METHODS: The Telemedical Project for Integrated Stroke Care is a telemedical network of 2 stroke centers and 12 regional general hospitals with newly established stroke wards in Bavaria. This analysis comprises all teleconsultations from 1st February 2003 to 15th December 2006. The consultations were prospectively documented and categorized according to predefined indications and direct impact on clinical decisions. The teleconsultations were analyzed concerning whether they were requested during regular working time or during off-time (at evening/night times or weekends).
RESULTS: A total of 10,239 teleconsultations were carried out in 8,326 patients. The 6,679 patients with cerebrovascular diagnosis comprised 51% of all admitted stroke cases between 2003 and 2006. During off-time 6,306 consultations (62%) were requested; 1,598 teleconsultations yielded nonstroke diagnoses, with 68% beyond working hours. Of all presented stroke patients 567 (8.5%) received systemic thrombolysis, with 58% off-time. Interhospital transports were initiated in 1,050 patients (10.5% of all), mainly for specific diagnostic workup or interventional treatments. Sixty percent of these transfers were launched off-time.
CONCLUSIONS: The majority of teleconsultations were requested beyond normal working times and a significant proportion had an immediate impact on clinical decisions. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18303252     DOI: 10.1159/000118378

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Stroke telemedicine: state of affairs.

Authors:  Bijan Vatankhah; Heinrich J Audebert
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

2.  Future neurohospitalist: teleneurohospitalist.

Authors:  William David Freeman; Kevin M Barrett; Kenneth A Vatz; Bart M Demaerschalk
Journal:  Neurohospitalist       Date:  2012-10

Review 3.  Teleneurology and mobile technologies: the future of neurological care.

Authors:  E Ray Dorsey; Alistair M Glidden; Melissa R Holloway; Gretchen L Birbeck; Lee H Schwamm
Journal:  Nat Rev Neurol       Date:  2018-04-06       Impact factor: 42.937

Review 4.  Teleneurology: is it really at a distance?

Authors:  S Agarwal; E A Warburton
Journal:  J Neurol       Date:  2011-02-11       Impact factor: 4.849

Review 5.  The history and future of telestroke.

Authors:  David C Hess; Heinrich J Audebert
Journal:  Nat Rev Neurol       Date:  2013-05-07       Impact factor: 42.937

6.  PreSSUB II: The prehospital stroke study at the Universitair Ziekenhuis Brussel II.

Authors:  Alexis Valenzuela Espinoza; Robbert-Jan Van Hooff; Ann De Smedt; Maarten Moens; Laetitia Yperzeele; Koenraad Nieboer; Ives Hubloue; Jacques De Keyser; Alain Dupont; Liesbet De Wit; Koen Putman; Raf Brouns
Journal:  J Transl Int Med       Date:  2015-06-30

7.  Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2).

Authors:  Sonu Bhaskar; Sian Bradley; Vijay Kumar Chattu; Anil Adisesh; Alma Nurtazina; Saltanat Kyrykbayeva; Sateesh Sakhamuri; Sebastian Moguilner; Shawna Pandya; Starr Schroeder; Maciej Banach; Daniel Ray
Journal:  Front Public Health       Date:  2020-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.